Orbitrex Peptides
Retatrutide
Finnrick tested 9 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Orbitrex Peptides between 7 Oct 2025 and 4 Mar 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Orbitrex Peptides
Retatrutide
Tested 9 Samples
Last test 4 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Orbitrex Peptides
Samples are tested in commercial labs
Tests Count
9
Scores
AVGMINMAX
Last
4 Mar 2026
First
7 Oct 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Mar 2026 | View | 36mg | (no batch claim) | 37.3mg | +3.6% | 99.90% | 3G361125 | Black Label / Gold Crimp / Clear Cap | Lab G | Public | |
| 2 Mar 2026 | View | 10mg | (no batch claim) | 11.5mg | +15.0% | 99.90% | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 13 Feb 2026 | View | 10mg | 11.3mg | 9.9mg | -12.2% | 99.90% | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 24 Nov 2025 | View | 20mg | ⚠️ Sample does not contain Retatrutide | 3G201125 | Black Label / Silver Crimp / Green Cap | Lab A | Vendor | ||||
| 23 Nov 2025 | View | 20mg | 23.1mg | 21.98mg | -5.0% | 99.87% | 3G201125 | Black Label / Silver Crimp / Green Cap | Lab A | Vendor | |
| 23 Nov 2025 | View | 20mg | 23.1mg | 22.25mg | -3.8% | 99.87% | 3G201125 | Black Label / Silver Crimp / Green Cap | Lab A | Vendor | |
| 23 Oct 2025 | View | 30.5mg | (no batch claim) | 30.1mg | -1.3% | 99.20% | RET309225 | Silver Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 23 Oct 2025 | View | 20mg | 24.0mg | 23.1mg | -3.9% | 99.95% | RET2082125 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 17 Oct 2025 | View | 30mg | (no batch claim) | 30mg | 99.95% | RET309225 | No Label / Silver Crimp / Violet Cap | Lab E | Public | ||
| 7 Oct 2025 | View | 30.5mg | (no batch claim) | 36.6mg | +20.0% | 99.70% | RET309225 | Silver Label / Silver Crimp / Violet Cap | Lab G | Public | |
Corrections
- 9 Mar 2026
- Sample p4bqre8: original COA reported purity of 97.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 3.7 to 7.0, and the Finnrick Rating for Orbitrex Retatrutide changed from D to A.